ilmscore | Prediction Details
By Groww | May 27, 2024 | Pending
Interpreted Prediction
Glenmark Pharma's management targets an EBITDA margin of 19% (likely for FY25 or beyond).

Prediction Details

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.